Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model
- 1 June 1997
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 41 (6) , 1215-1219
- https://doi.org/10.1128/aac.41.6.1215
Abstract
In an in vitro dynamic model we compared the antimicrobial effects of two carbapenems, imipenem (MIC, 1 microg/ml) and meropenem (MIC, 0.25 microg/ml) on Pseudomonas aeruginosa. The antibiotics were administered either as short-time infusions once or three times a day or as continuous infusions with steady-state levels ranging from 0.5 to 20 microg/ml. From the resulting kill curves the period of time until the onset of bacterial death (dt), the rate constant of bacterial death (ka), the maximal reduction of CFU (mr), and the period of time until bacterial regrowth occurred (tr) were determined. Additionally, the occurrence of bacterial resistance during the simulations (rq) and the postantibiotic effect (PAE) were recorded. For both investigated carbapenems no significant difference in dt, ka, mr, and PAE values between the short-time infusions and continuous infusions with steady-state levels above 2 microg/ml could be detected. The tr was longest with continuous infusions of over approximately 24 h, corresponding to steady-state levels of 3 microg/ml for imipenem and 2.5 microg/ml for meropenem. An increase in MIC was observed only during continuous infusions with steady-state levels below 2 microg/ml. Independent of the chosen method of application and despite the lower MIC of meropenem, imipenem was slightly more effective than meropenem.Keywords
This publication has 16 references indexed in Scilit:
- Mathematical corrections for bacterial loss in pharmacodynamic in vitro dilution modelsAntimicrobial Agents and Chemotherapy, 1995
- Continuous infusion of beta-lactam antibioticsAntimicrobial Agents and Chemotherapy, 1992
- Comparative study of pharmacokinetics and serum bactericidal activities of cefpirome, ceftazidime, ceftriaxone, imipenem, and ciprofloxacinAntimicrobial Agents and Chemotherapy, 1992
- Pharmacokinetics of meropenem in subjects with various degrees of renal impairmentAntimicrobial Agents and Chemotherapy, 1992
- CONTINUOUS INFUSION OF CEFTAZIDIME IN CYSTIC FIBROSISThe Lancet, 1989
- Continuous-infusion ampicillin therapy of enterococcal endocarditis in ratsAntimicrobial Agents and Chemotherapy, 1987
- Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic ratsAntimicrobial Agents and Chemotherapy, 1986
- Multiple-dose pharmacokinetics of imipenem-cilastatinAntimicrobial Agents and Chemotherapy, 1984
- The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteersEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984
- Efficacy of continuous versus intermittent administration of penicillin G inStreptococcus pneumoniae pneumonia in normal and immunodeficient ratsEuropean Journal of Clinical Microbiology & Infectious Diseases, 1984